Early removal prevents over 90% of colorectal cancers, says Professor Moon Jung-rak of Kyung Hee University Hospital at Gangdong ...
This dual-immunotherapy neoadjuvant treatment regimen is mainly intended for patients with resectable stage IIB to III colon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback